Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 2

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04909476Unknown

Tracheal Intubation in COVID-19 Patients

Role: lead

NCT04905875Unknown

Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry

Role: lead

NCT03489759Not ApplicableUnknown

The Effect of Vitamin E-coated Polysulfone Membrane on Oxidative Stress, Inflammation and Monocytes in Critically Ill Patients in CRRT

Role: lead

NCT03747731Unknown

A Non-invasive Evaluation of Kidney-Lung Interactions

Role: lead

NCT03443219Not ApplicableCompleted

RCT- LMA Supreme™ Versus the Spritztube® Tracheal Cannula in Anesthetized Adult Patients

Role: lead

NCT00992134Phase 2Completed

Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma

Role: lead

NCT00629382Phase 4Completed

Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis

Role: lead

All 7 trials loaded